Xcout IntelSign inSubscribe

Weitao Biotech

Biotechnology

Weitao Biotech (operating as IQVIA Biotech) functions as a specialized, full-service contract research organization (CRO) supporting biotech and biopharmaceutical companies globally. It provides clinical development solutions and therapeutic expertise across various fields, including oncology, cell and gene therapy, central nervous system studies, cardiovascular, renal and metabolic diseases, dermatology, and internal medicine.

Subscribe to see Weitao Biotech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Weitao Biotech at a glance

Weitao Biotech is a biotechnology company. Its most recent funding round, Series A, raised $50M in April 2026. Xcout tracks 10 named people at Weitao Biotech, including Peter Ronco (President).

Industry
Biotechnology

Weitao Biotech leadership

  • Peter RoncoPresident
  • Jim RouttChief Operating Officer
  • James Kyle Bryan, MDChief Medical Officer
  • Liu YarongFounder and CEO
  • Cynthia Venendaal, PhD, MPHVice President, Clinical Operations
  • Lynn AdamsVice President, Internal Medicine & Dermatology

4 more named people on record for Weitao Biotech, with roles, board committees and tenure — see the full roster →

Weitao Biotech funding rounds

Every round on record:

DateRoundAmountInvestors
Series A$50M9 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Investors

Weitao Biotech competitors

A few of Weitao Biotech's closest competitors — see the full list of competitors and alternatives →

VIVA BIOTECH01873 · BiotechShanghai, China
70% matchPublic

Viva Biotech Holdings, founded in 2008 and based in Shanghai, China, operates as an investment holding company primarily dedicated to providing comprehensive, structure-based drug discovery services to biotechnology and pharmaceutical clients worldwide. Its extensive discovery biology offerings encompass protein expression and purification, structural biology, hit identification, bioassay development, biomolecular interaction analysis, and pharmacokinetic studies. The company also delivers a suite of chemistry services, including medicinal and synthetic chemistry, analytical services, preparative purification, and computer-aided drug design, all supported by robust chemical technology platforms. Viva Biotech further specializes in antibody drug research and development, covering antigen preparation, multi-species antibody discovery, monoclonal antibody production, functional screening and characterization, antibody engineering, and cell line engineering. This work is facilitated by cutting-edge technological platforms such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high-throughput sequencing, computer-aided drug design, HDX-MS, protein crystal structure determination, and SPR technology. Beyond its core service offerings, Viva Biotech provides various biological resources, including cell lines, crystal structures, GPCR proteins, antibodies, and other purified proteins. The company also offers contract development and manufacturing (CDMO) services for small molecule active pharmaceutical ingredients (APIs) and their intermediates. Furthermore, it engages in the trading of APIs, intermediates, and formulations, and operates under an "equity for service" model. Additional services include general research, laboratory facility rentals, project management and bidding assistance, and the sale of chemical compounds.

Market cap$396.6M
Employees2,169
VIVA BIOTECH competitors & alternatives →

Get Weitao Biotech's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Weitao Biotech? Suggest a correction · Work at Weitao Biotech? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Weitao Biotech on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Weitao Biotech — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Weitao Biotech in Xcout Intel

  • 10 named people with titles, LinkedIn and board committees
  • 1 funding round with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →